Hence, a protective action of IL-22 on airway allergic inflammation, in particular on airway eosinophilic inflammation and Th2 cytokine production, on AHR and even on some pathological feature of airway remodeling (goblet cell hyperplasia) has been described in several studies (127–129, 131). This evidence concerns the gene IL22 and inflammatory response.